MRI Interventions, Inc.
1101 East 33rd Street
Suite B307
Baltimore
Maryland
21218
United States
Tel: 443-451-7380
Fax: 410-614-6941
Website: http://www.surgivision.com/
145 articles about MRI Interventions, Inc.
-
MRI Interventions, Inc. Changes Corporate Name to ClearPoint Neuro, Inc.Company To Commence Trading Under Ticker Symbol CLPT on February 12, 2020
2/11/2020
MRI Interventions, Inc., a leading platform neurosurgery company, will effectuate its previously announced change of its corporate name to ClearPoint Neuro, Inc.
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2019 Results February 12Release and Call After Market Close
2/11/2020
ClearPoint Neuro, Inc. announced that it will release financial results for its 2019 fourth quarter and full year, which ended December 31, 2019, on Wednesday, February 12, 2020 after the market close.
-
MRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
1/29/2020
MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, closed its previously announced $17.5 million strategic investment from PTC Therapeutics, Inc. (“PTC”) and Petrichor Healthcare Capital Management (“Petrichor”), with $10.0 million of notes funded by PTC and $7.5 million of notes funded by Petrichor.
-
MRI Interventions, Inc. To Change Corporate Name to ClearPoint Neuro, Inc.
1/13/2020
MRI Interventions, Inc., a leading platform neurosurgery company, announced plans to change its corporate name to ClearPoint Neuro, Inc.
-
MRI Interventions, Inc. Obtains a $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
1/13/2020
MRI Interventions, Inc., a leading platform neurosurgery company, announced preliminary and unaudited results for the quarter ended December 31, 2019.
-
MRI Interventions Reports 62% Increase in 2019 Third Quarter Revenue
11/12/2019
MRI Interventions, Inc. announced financial results for its third fiscal quarter ended September 30, 2019.
-
MRI Interventions, Inc. to Announce Third Quarter 2019 Results on November 12
11/6/2019
MRI Interventions, Inc. (NYSE American: MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will release financial results for its 2019 third quarter, which ended September 30, 2019, on Tuesday, November 12, 2019 after the market close
-
PTC Therapeutics and MRI Interventions Announce Strategic Investment
5/9/2019
$4 million equity investment to advance delivery device R&D for CNS gene therapy portfolio and other company operations
-
MRI-guided Neurosurgical Ablation Market to Exceed A Value of US$ 216.3 Million During 2018 to 2028
9/25/2018
The global MRI-guided neurosurgical ablation market is projected to expand at a CAGR of 4.9% during the forecast period 2018–2028 and reach US$ 216.3 Mn by the end of 2028.
-
MRI Interventions Reports Second Quarter of 2018 Results
8/14/2018
MRI Interventions, Inc. announced financial results for its second fiscal quarter ended June 30, 2018.
-
MRI Interventions, Inc. to Announce Second Quarter 2018 Results on August 14
8/7/2018
MRI Interventions, Inc. announced that it will release financial results for its 2018 second quarter, which ended June 30, 2018, on Tuesday, August 14, 2018 after the market close.
-
AirXpanders Announces New CEO
6/14/2018
AirXpanders, Inc., (ASX: AXP), announced that it has appointed a new President and CEO, Mr. Frank Grillo.
-
MRI Interventions, Inc. Announces Record 629 ClearPoint Cases in 2017
2/6/2018
2017 Functional Neurology Product Revenue Increases 34%, Total Revenue Increases 28% Over 2016.
-
MRI Interventions Recognizes FDA Clearance of Voyager’s Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson’s Disease
1/24/2018
Clearance of the IND allows Voyager to formally initiate clinical trial sites and begin screening patients for its pivotal Phase 2-3 program.
-
MRI Interventions ClearPoint Neuro Navigation System Utilized for the First Time in Minnesota
1/3/2018
University of Minnesota Health offers real-time MRI guided minimally invasive brain surgery.
-
MRI Interventions’ ClearPoint NeuroNavigation System Achieves 2000th Procedure Milestone
11/16/2017
The procedure was done by Dr. William Anderson at Johns Hopkins University.
-
MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures
11/7/2017
Total revenue increased 6% to $1.7 million, from $1.6 million in the same period of 2016, reflecting a 12% increase in disposable sales, offset by lower capital equipment sales.
-
MRI Interventions, Inc. to Announce Third Quarter 2017 Financial Results on November 6
10/31/2017
The company will subsequently conduct a conference call and webcast to review its results at 4:30 p.m. ET.
-
MRI Interventions Names Former Royal Philips Electronics N.V. Exec as New CEO
10/9/2017
-
MRI Interventions’ Clearpoint Neuro-Navigation System To Be Featured At The Congress Of Neurological Surgeons (CNS), In A Hands-On Laser Ablation Surgery Workshop
10/3/2017